PD-L1 is a checkpoint protein which binds to PD-1 on activated T- and B-cells, especially CD8+ cells, to suppress their anti-tumour response [81], thereby ensuring tumour cell survival and evasion. This evidence concerns the gene CD8A and neoplasm.